Structural Formula 1 (C1328cfd Figure 01)
Candesartan Cilexetil And Hydrochlorothiazide Tablet
Product Images NDC 43547-461
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil And Hydrochlorothiazide (NDC 43547-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula 2 (C1328cfd Figure 02)
16/12.5 mg 90 Counts (C1328cfd Figure 03)
This medication with NDC number 43547-459-09 is a combination of candesartan cilexetil and hydrochlorothiazide, used by adults as per usual dosage. Each tablet has 16 grams of candesartan cilexetil and 12.5 mg of hydrochlorothiazide. It is stored in a closed container, at a temperature ranging from 20 to 25°C. This drug is manufactured by Zhejiang Huahai Pharmaceutical Co, Ltd and distributed by Solco Healthcare US, LLC. The provided text does not contain any non-English characters.*
32/12.5 mg 90 Counts (C1328cfd Figure 04)
32/25 mg 90 Counts (C1328cfd Figure 05)
Each tablet of NDC415A7451 contains 32 mg of candesartan cilexetil, USP, and 25 mg of nyorochlorotriazide, USP. This medication is meant for adult use only, and the recommended dosage can be found in the package insert. It should be stored at a temperature of 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). The tablets are manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. and distributed by an unknown company. The revision date of this information is March 12, 2020.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
